Abstract
Background: Patients with epilepsy often suffer from other important conditions. The existence of such co-morbidities is frequently not recognized and their relationship with epilepsy usually remains unexplained. Methodology/Principal Findings: We describe three patients with common, sporadic, non-syndromic epilepsies in whom large genomic microdeletions were found during a study of genetic susceptibility to epilepsy. We performed detailed gene-driven clinical investigations in each patient. Disruption of the function of genes in the deleted regions can explain co-morbidities in these patients. Conclusions/Significance: Co-morbidities in patients with epilepsy can be part of a genomic abnormality even in the absence of (known) congenital malformations or intellectual disabilities. Gene-driven phenotype examination can also reveal clinically significant unsuspected condition. © 2011 Kasperavičiute et al.
Cite
CITATION STYLE
Kasperavičiute, D., Catarino, C. B., Chinthapalli, K., Clayton, L. M. S., Thom, M., Martinian, L., … Sisodiya, S. M. (2011). Uncovering genomic causes of co-morbidity in epilepsy: Gene-driven phenotypic characterization of rare microdeletions. PLoS ONE, 6(8). https://doi.org/10.1371/journal.pone.0023182
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.